| scholarly article | Q13442814 |
| P50 | author | Yuji Matsuzawa | Q109941911 |
| P2093 | author name string | Kenji Saisho | |
| Kiyonori Katsuragi | |||
| Koji Yamamoto | |||
| Mitsuaki Kyo | |||
| Sachiko Tamba | |||
| Yasumitsu Takahi | |||
| Yoshinari Obata | |||
| Yuya Yamada | |||
| P2860 | cites work | Clinical significance of high-molecular weight form of adiponectin in male patients with coronary artery disease | Q46833344 |
| Low serum levels of total and high-molecular-weight adiponectin predict the development of metabolic syndrome in Japanese-Americans | Q47400622 | ||
| Natriuretic peptides enhance the production of adiponectin in human adipocytes and in patients with chronic heart failure | Q47705098 | ||
| Serum adiponectin is a predictor of coronary heart disease: a population-based 10-year follow-up study in elderly men. | Q51485041 | ||
| Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. | Q51555890 | ||
| New criteria for 'obesity disease' in Japan. | Q53667063 | ||
| Adiponectin and Coronary Heart Disease | Q57416324 | ||
| Vascular Risk Factors and Diabetic Neuropathy | Q58207583 | ||
| Obesity and type 2 diabetes in Japanese patients | Q58207650 | ||
| Adiponectin and Coronary Heart Disease: The Strong Heart Study | Q59921177 | ||
| Decreased plasma adiponectin concentration in patients with essential hypertension | Q78761981 | ||
| Association of hypoadiponectinemia with coronary artery disease in men | Q78780687 | ||
| Increment and impairment of adiponectin in renal failure | Q82340233 | ||
| Determination of adiponectin in serum using a latex particle-enhanced turbidimetric immunoassay with an automated analyzer | Q83377804 | ||
| Assessment of adiponectin and the risk of recurrent cardiovascular events in patients presenting with an acute coronary syndrome: observations from the Pravastatin Or atorVastatin Evaluation and Infection Trial-Thrombolysis in Myocardial Infarction | Q84274776 | ||
| Evidence-based practice guideline for the treatment of CKD | Q84978295 | ||
| Absolute value of visceral fat area measured on computed tomography scans and obesity-related cardiovascular risk factors in large-scale Japanese general population (the VACATION-J study) | Q85235544 | ||
| Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin | Q22010955 | ||
| Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-kappaB signaling through a cAMP-dependent pathway | Q24290228 | ||
| The role of the novel adipocyte-derived hormone adiponectin in human disease | Q24296429 | ||
| High-molecular-weight adiponectin and the risk of type 2 diabetes in the ARIC study | Q24618394 | ||
| Adiponectin and future coronary heart disease events among men with type 2 diabetes | Q28213958 | ||
| International clinical harmonization of glycated hemoglobin in Japan: From Japan Diabetes Society to National Glycohemoglobin Standardization Program values | Q33585669 | ||
| Causes of death in Japanese diabetics: A questionnaire survey of 18,385 diabetics over a 10-year period | Q33609528 | ||
| Report of the committee on the classification and diagnostic criteria of diabetes mellitus | Q33609765 | ||
| The metabolic syndrome and adipocytokines | Q33995630 | ||
| cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (AdiPose Most abundant Gene transcript 1). | Q34377772 | ||
| Effects of peroxisome proliferator-activated receptor ligands, bezafibrate and fenofibrate, on adiponectin level | Q34573662 | ||
| Selective suppression of endothelial cell apoptosis by the high molecular weight form of adiponectin | Q35218879 | ||
| Plasma total and high molecular weight adiponectin levels and risk of coronary heart disease in women | Q35501308 | ||
| Implications of plasma concentrations of adiponectin in patients with coronary artery disease | Q35582303 | ||
| Adiponectin: an independent risk factor for coronary heart disease in men in the Framingham offspring Study | Q36870960 | ||
| Diabetes in Asia: epidemiology, risk factors, and pathophysiology | Q37496434 | ||
| Adiponectin levels and risk of type 2 diabetes: a systematic review and meta-analysis | Q37543864 | ||
| Globular adiponectin protected ob/ob mice from diabetes and ApoE-deficient mice from atherosclerosis | Q38361016 | ||
| Plasma adiponectin levels are associated with insulin resistance, but do not predict future risk of coronary heart disease in women | Q40400158 | ||
| PPARgamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein | Q42826174 | ||
| Pravastatin potentiates increases in serum adiponectin concentration in dyslipidemic patients receiving thiazolidinedione: the DOLPHIN study | Q42940160 | ||
| Adiponectin, metabolic risk factors, and cardiovascular events among patients with end-stage renal disease | Q43829986 | ||
| Decreased plasma adiponectin concentrations in women with dyslipidemia | Q44018162 | ||
| Adiponectin in essential hypertension. | Q44232111 | ||
| Serum level of triglycerides is a potent risk factor comparable to LDL cholesterol for coronary heart disease in Japanese patients with type 2 diabetes: subanalysis of the Japan Diabetes Complications Study (JDCS). | Q44233624 | ||
| Blockade of the renin-angiotensin system increases adiponectin concentrations in patients with essential hypertension | Q44471484 | ||
| Adiponectin stimulates production of nitric oxide in vascular endothelial cells. | Q44565932 | ||
| Plasma adiponectin levels and risk of myocardial infarction in men. | Q44843420 | ||
| Total and high molecular weight adiponectin, haemodynamics, and mortality in patients with chronic heart failure | Q45033818 | ||
| Serum adiponectin is increased in type 1 diabetic patients with nephropathy | Q46513463 | ||
| Is the diagnosis of metabolic syndrome useful for predicting cardiovascular disease in asian diabetic patients? Analysis from the Japan Diabetes Complications Study | Q46513487 | ||
| Plasma adiponectin, body mass index, and mortality in patients with chronic heart failure | Q46699229 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | coronary artery disease | Q844935 |
| P304 | page(s) | 475-482 | |
| P577 | publication date | 2013-05-26 | |
| P1433 | published in | Journal of Diabetes Investigation | Q28207066 |
| P1476 | title | Serum adiponectin levels predict the risk of coronary heart disease in Japanese patients with type 2 diabetes | |
| P478 | volume | 4 |
| Q35879311 | Association between the level of circulating adiponectin and prediabetes: A meta-analysis |
| Q55057455 | Associations between three common single nucleotide polymorphisms (rs266729, rs2241766, and rs1501299) of ADIPOQ and cardiovascular disease: a meta-analysis. |
| Q50159078 | Serum adiponectin levels predict acute coronary syndrome (ACS) in patients with severe carotid stenosis |
| Q34994425 | Systemic arteriosclerosis and eating behavior in Japanese type 2 diabetic patients with visceral fat accumulation |
| Q57032380 | The effects of dietary instruction on cardiovascular risk markers after smoking cessation: study protocol for a multicenter randomized controlled trial in Japan |
Search more.